Lanean...
Lifitegrast: A novel drug for treatment of dry eye disease
Dry eye disease (DED) is an inflammatory disorder of ocular surfaces leading to severe disability, especially in the elderly age group. The mainstay of therapy includes artificial tears, punctual plugs, topical anti-inflammatory agents, and corticosteroids. In the past few years, only cyclosporine-A...
Gorde:
| Argitaratua izan da: | J Pharmacol Pharmacother |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Medknow Publications & Media Pvt Ltd
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5242036/ https://ncbi.nlm.nih.gov/pubmed/28163544 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0976-500X.195920 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|